---
title: Webinar - aboBoNT in Post-operative pain
description: Pain after surgery remains a significant healthcare challenge. Here, abobot- ulinumtoxinA (aboBoNT-A, Dysport®) was assessed in a post-surgical pain model in pigs.
---

[![mdbiosciences-logo-reversed](https://www.mdbneuro.com/hs-fs/hubfs/mdbiosciences-logo-reversed.png?width=600&height=130&name=mdbiosciences-logo-reversed.png)

![MD Biosciences Neuro logo-4](https://www.mdbneuro.com/hs-fs/hubfs/MD%20Biosciences%20Neuro%20logo-4.png?width=423&height=64&name=MD%20Biosciences%20Neuro%20logo-4.png) 

](https://www.mdbneuro.com)

[![Request Proposal](https://no-cache.hubspot.com/cta/default/42723/3821f32c-96e0-4877-b588-1e48960b10b2.png)](https://cta-redirect.hubspot.com/cta/redirect/42723/3821f32c-96e0-4877-b588-1e48960b10b2)

[**](https://www.mdbneuro.com/webinar-registration-analgesic-activity-pop#tmpdnd_area-module-1)

**

##### About Us

##### Webinars:

##### Cell-based Assays

##### Efficacy Models

##### Assessments

##### PK/PD & Toxicology

##### Pain

##### Neurodegeneration

##### Neuroinflammation

##### Wound Healing

##### Content

##### Whitepapers:

# Translational Model of Post-operative Pain

#### Evaluating the analgesic activity of AbobotulinumtoxinA to warrant clinical investigation.

 

#### .

 

[Watch Webinar](https://www.mdbneuro.com/webinar-registration-analgesic-activity-pop#webinar-form)

### About this webinar:

Pain after surgery remains a significant healthcare challenge. Here, abobot- ulinumtoxinA (aboBoNT-A, Dysport®) was assessed in a post-surgical pain model in pigs. In this study, we assessed mechanical sensitivity, distress behaviors, latency to approach the investigator, and wound inflammation/healing followed by immunohistochemistry and biomarkers to understand the mechanism of action and warrant moving forward with clinical investigation. 

![webinar analgesic activity](https://www.mdbneuro.com/hs-fs/hubfs/Webinar%20images/webinar%20analgesic%20activity.png?width=600&height=600&name=webinar%20analgesic%20activity.png)

**Mikhail Kalinichev, Ph.D  
**Head of Translational Science Addex Therapeutics

 

## Watch the On-demand Webinar now.

 

 

[![mdbiosciences-logo-reversed](https://www.mdbneuro.com/hubfs/mdbiosciences-logo-reversed.png) ](https://www.mdbneuro.com)

Copyright © 2024 MD Biosciences

[**](https://www.facebook.com/mdbiosciences1/)[**](https://twitter.com/mdbneuro)[**](https://www.instagram.com/mdbneuro)[**](https://www.linkedin.com/company/mdbiosciences)

**

![](https://px.ads.linkedin.com/collect/?pid=3993628&fmt=gif)